Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
T2 Relaxometry
33%
Hypoglycorrhachia
33%
Morbidity Outcome
33%
Growth Trajectory
33%
Toddlers
33%
Long-term Growth
33%
Brain Dysplasia
33%
Outer Mitochondrial Membrane
33%
Early Speech
33%
Developmental Phenotype
33%
Childhood Immune Thrombocytopenia
33%
Predictors of Remission
33%
Immune Thrombocytopenia
33%
Preterm Birth
33%
Antibiotic Exposure
33%
Birth children
33%
Weight for Gestational Age
33%
Risk Factors
33%
Cerebral Palsy
33%
Risk Disease
33%
Neurodevelopmental Trajectory
33%
Influenza-associated Encephalopathy
33%
Disease Trajectory
33%
Chronic Immune Thrombocytopenia
33%
Speech Production
33%
Threshold of Viability
33%
Late Diagnosis
33%
Neonatal Resuscitation Program
33%
Periviable Infants
33%
National Cohort Study
33%
Taiwan
33%
Pediatric Traumatic Brain Injury
33%
Delayed Remission
23%
Neurodevelopmental Phenotypes
20%
Preterm Neonates
20%
Typically Developing Infants
16%
Two-year-olds
16%
Childhood ITP
16%
Volubility
16%
Mental Performance
16%
Consonants
16%
T2 Relaxation Time
14%
Glucose Transporter Type 1 Deficiency Syndrome
13%
Dysmaturation
13%
Acute Presentation
13%
Cerebellar Lesion
11%
Pathogen Survey
11%
EBV DNA
11%
Autism Diagnostic Interview-Revised (ADI-R)
10%
Reciprocal Social Interaction
10%
Medicine and Dentistry
Idiopathic Thrombocytopenic Purpura
100%
Cohort Analysis
66%
Gestational Age
66%
Corpus Callosum
33%
Spontaneous Remission
33%
Relaxometry
33%
Diseases
33%
Pediatrics
33%
Pervasive Developmental Disorder
33%
Premature Labor
33%
Newborn Screening
33%
Closed Head Injury
33%
Newborn Morbidity
33%
Thyrotropin
33%
Neonatal Resuscitation Program
33%
Platelet
26%
Hemophagocytic Lymphohistiocytosis Syndrome
22%
Recurrent Disease
13%
Surfactant Therapy
11%
Neurodevelopmental Assessment
11%
RNA Immunization
11%
Cerebellum Injury
11%
Fatality
9%
Opisthotonus
8%
Embryonic Hemoglobin
8%
Tongue Thrust
8%
Opsoclonus
8%
Developmental Milestone
8%
Small for Gestational Age
7%
Acute Brain Disease
6%
Brain Growth
6%
Hazard Ratio
6%
Status Epilepticus
6%
Oseltamivir
6%
Peramivir
6%
Odds Ratio
5%
Hormone Determination
5%
